Loading...
Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients
BACKGROUND: Over 20 % of ovarian cancer patients have preoperative thrombocytosis or hyperfibrinogenemia. We aimed to demonstrate the clinical and prognostic significance of thrombocytosis and hyperfibrinogenemia in high-grade serous ovarian cancer (HGSC). METHODS: We retrospectively investigated HG...
Saved in:
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4730624/ https://ncbi.nlm.nih.gov/pubmed/26817451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2070-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|